Advertisement
APYX vs POCI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APYX is a Buy and POCI is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
APYX’s FA Score shows that 0 FA rating(s) are green whilePOCI’s FA Score has 1 green FA rating(s).
- APYX’s FA Score: 0 green, 5 red.
- POCI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
APYX’s TA Score shows that 1 TA indicator(s) are bullish while POCI’s TA Score has 3 bullish TA indicator(s).
- APYX’s TA Score: 1 bullish, 7 bearish.
- POCI’s TA Score: 3 bullish, 6 bearish.
Price Growth
APYX (@Medical/Nursing Services) experienced а -1.51% price change this week, while POCI (@Pharmaceuticals: Other) price change was -4.79% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.32%. For the same industry, the average monthly price growth was +5.07%, and the average quarterly price growth was +26.33%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.17%. For the same industry, the average monthly price growth was +4.33%, and the average quarterly price growth was +17.28%.
Reported Earning Dates
APYX is expected to report earnings on Nov 06, 2025.
Industries' Descriptions
@Medical/Nursing Services (+0.32% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (-1.17% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| APYX | POCI | APYX / POCI | |
| Capitalization | 74.1M | 34.3M | 216% |
| EBITDA | -10.64M | -5.34M | 199% |
| Gain YTD | 24.051 | -7.158 | -336% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 46.5M | 17.6M | 264% |
| Total Cash | 29.3M | 2.55M | 1,150% |
| Total Debt | 39.1M | 2.11M | 1,857% |
APYX | POCI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 52 Fair valued | 84 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 86 | |
SMR RATING 1..100 | 99 | 97 | |
PRICE GROWTH RATING 1..100 | 42 | 77 | |
P/E GROWTH RATING 1..100 | 100 | 4 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
APYX's Valuation (52) in the Medical Specialties industry is in the same range as POCI (84) in the null industry. This means that APYX’s stock grew similarly to POCI’s over the last 12 months.
POCI's Profit vs Risk Rating (86) in the null industry is in the same range as APYX (100) in the Medical Specialties industry. This means that POCI’s stock grew similarly to APYX’s over the last 12 months.
POCI's SMR Rating (97) in the null industry is in the same range as APYX (99) in the Medical Specialties industry. This means that POCI’s stock grew similarly to APYX’s over the last 12 months.
APYX's Price Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for POCI (77) in the null industry. This means that APYX’s stock grew somewhat faster than POCI’s over the last 12 months.
POCI's P/E Growth Rating (4) in the null industry is significantly better than the same rating for APYX (100) in the Medical Specialties industry. This means that POCI’s stock grew significantly faster than APYX’s over the last 12 months.
| APYX | POCI | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 4 days ago 87% | 4 days ago 81% |
| Momentum ODDS (%) | 4 days ago 86% | 4 days ago 83% |
| MACD ODDS (%) | 4 days ago 90% | 4 days ago 80% |
| TrendWeek ODDS (%) | 4 days ago 83% | 4 days ago 73% |
| TrendMonth ODDS (%) | 4 days ago 86% | 4 days ago 73% |
| Advances ODDS (%) | 18 days ago 87% | 20 days ago 62% |
| Declines ODDS (%) | 6 days ago 85% | 4 days ago 72% |
| BollingerBands ODDS (%) | N/A | 4 days ago 84% |
| Aroon ODDS (%) | 4 days ago 90% | 4 days ago 69% |
Advertisement
APYX and
Correlation & Price change
A.I.dvisor indicates that over the last year, APYX has been loosely correlated with CORBF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APYX jumps, then CORBF could also see price increases.
| Ticker / NAME | Correlation To APYX | 1D Price Change % | ||
|---|---|---|---|---|
| APYX | 100% | -4.39% | ||
| CORBF - APYX | 36% Loosely correlated | N/A | ||
| CLPT - APYX | 27% Poorly correlated | -0.27% | ||
| INGN - APYX | 26% Poorly correlated | -0.12% | ||
| EMBC - APYX | 25% Poorly correlated | +3.24% | ||
| INFU - APYX | 25% Poorly correlated | -4.42% | ||
More | ||||
POCI and
Correlation & Price change
A.I.dvisor tells us that POCI and NSYS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POCI and NSYS's prices will move in lockstep.
| Ticker / NAME | Correlation To POCI | 1D Price Change % | ||
|---|---|---|---|---|
| POCI | 100% | -2.52% | ||
| NSYS - POCI | 26% Poorly correlated | +1.31% | ||
| LUCD - POCI | 22% Poorly correlated | -0.72% | ||
| APYX - POCI | 21% Poorly correlated | -4.39% | ||
| CNTGF - POCI | 21% Poorly correlated | +5.45% | ||
| STXS - POCI | 21% Poorly correlated | +5.07% | ||
More | ||||